Pelin
Pelin Aksit, Cromwell, CT US
Patent application number | Description | Published |
---|---|---|
20090256567 | THREE-POINT METHOD AND SYSTEM FOR FAST AND ROBUST FIELD MAPPING FOR EPI GEOMETRIC DISTORTION CORRECTION - A system and method for MR magnetic field mapping includes a computer programmed to acquire a first data point at a first location in a first phase image data set, a second data point at the first location in a second phase image data set, a third data point at the first location in a third phase image data set. The first, second, and third phase images are acquired using a first, second, and third TE, respectively. Phase wrapping does not occur among the first and second phase image data sets; however, phase wrapping does occur among the second and third phase image data sets. The computer is also programmed to determine a magnetic field inhomogeneity, wherein the determination of the magnetic field inhomogeneity is based on the first, second, and third data points. | 10-15-2009 |
Pelin Gunenc, Teddington GB
Patent application number | Description | Published |
---|---|---|
20090214609 | Oral Polyphosphate Compositions - The present invention relates to a dentifrice composition comprising: | 08-27-2009 |
Pelin Hacarlioglu, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20160122266 | PRODUCTION OF SHORT CHAIN PERFLUOROALKYL IODIDES FROM HIGHER ORDER TELOMERS - An improved process for producing perfluoroalkyl iodides of formula (I) | 05-05-2016 |
Pelin SahlÉn, Uppsala SE
Patent application number | Description | Published |
---|---|---|
20160076081 | Targeted Chromosome Conformation Capture - The invention relates to a method which enables the possibility to capture chromosome conformation as well as a kit containing components useful to be used the method, such as to detect promoter and enhancer relations. The method comprises the following steps: i) providing cross-linked genomic DNA, wherein the DNA comprises a first and a second set of regions, ii) fragmenting the cross-linked genome, thus creating a plurality of fragments with junctions, iii) adding a labelled junction marker such as biotin and ligating the fragments to the marker, iv) purifying the marked fragments, v) adding labelled capture probes and selectively purifying the hybridised fragments, and vi) analysing the fragments captured by hybridisation and identify the fragments. | 03-17-2016 |